Insider Transactions in Q1 2025 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.29 P/Share
|
|
Mar 31
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.29 P/Share
|
|
Mar 31
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.29 P/Share
|
|
Mar 31
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.29 P/Share
|
|
Mar 28
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.2 P/Share
|
|
Mar 28
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.2 P/Share
|
|
Mar 28
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.2 P/Share
|
|
Mar 28
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.2 P/Share
|
|
Mar 27
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.2 P/Share
|
|
Mar 27
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.2 P/Share
|
|
Mar 27
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.2 P/Share
|
|
Mar 27
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.2 P/Share
|
|
Mar 26
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.41 P/Share
|
|
Mar 26
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.41 P/Share
|
|
Mar 26
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.41 P/Share
|
|
Mar 26
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.41 P/Share
|
|
Mar 25
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.45 P/Share
|
|
Mar 25
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.45 P/Share
|
|
Mar 25
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.45 P/Share
|
|
Mar 25
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.45 P/Share
|
|
Mar 24
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
45
+0.02%
|
$180
$4.42 P/Share
|
|
Mar 24
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
8
+0.0%
|
$32
$4.42 P/Share
|
|
Mar 24
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
8
+0.02%
|
$32
$4.42 P/Share
|
|
Mar 24
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
4
+0.01%
|
$16
$4.42 P/Share
|
|
Mar 21
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$148
$4.89 P/Share
|
|
Mar 21
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$28
$4.89 P/Share
|
|
Mar 21
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$28
$4.89 P/Share
|
|
Mar 21
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$12
$4.89 P/Share
|
|
Mar 20
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.07 P/Share
|
|
Mar 20
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.07 P/Share
|
|
Mar 20
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.07 P/Share
|
|
Mar 20
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.07 P/Share
|
|
Mar 19
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.41 P/Share
|
|
Mar 19
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.41 P/Share
|
|
Mar 19
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.41 P/Share
|
|
Mar 19
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.41 P/Share
|
|
Mar 18
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.12 P/Share
|
|
Mar 18
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.12 P/Share
|
|
Mar 18
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.12 P/Share
|
|
Mar 18
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.12 P/Share
|
|
Mar 17
2025
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
37
+0.01%
|
$185
$5.41 P/Share
|
|
Mar 17
2025
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
7
+0.0%
|
$35
$5.41 P/Share
|
|
Mar 17
2025
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
7
+0.02%
|
$35
$5.41 P/Share
|
|
Mar 17
2025
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
3
+0.01%
|
$15
$5.41 P/Share
|
|
Mar 17
2025
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.88%
|
$25,000
$5.17 P/Share
|
|
Mar 17
2025
|
Caroline Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+3.0%
|
$5,000
$5.17 P/Share
|
|
Mar 17
2025
|
Martin S Brown Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+10.53%
|
$5,000
$5.17 P/Share
|
|
Mar 17
2025
|
Joseph C Galante Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.59%
|
$5,000
$5.17 P/Share
|
|
Mar 17
2025
|
James Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+2.29%
|
$5,000
$5.17 P/Share
|
|
Mar 17
2025
|
A J Kazimi Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,558
-0.06%
|
$17,790
$5.17 P/Share
|